U.S. deploys bulk of stealthy long-range missile for Iran war

The US has reallocated nearly its entire JASSM-ER inventory to the Iran campaign, leaving ~425 of a prewar 2,300 JASSM-ERs available globally after moving stockpiles to CENTCOM and Fairford; each JASSM-ER is valued at ~$1.5M. US operations have consumed >1,000 JASSM-ERs and roughly two-thirds of JASSM stockpiles overall, creating multi-year replacement needs given Lockheed’s 2026 scheduled JASSM-ER production of 396 units (up to 860 if fully retooled). Defense supply stress extends to interceptors and Tomahawks (prewar ~4,000; RTX produced ~100 in 2025 and upgraded ~240), raising material and production risks for defense contractors and strategic coverage gaps against other near-peer adversaries.

Analysis

The operational decision to reallocate a strategic long‑range strike inventory to the current theater creates a durable two‑theater capability tradeoff: near‑term CENTCOM strike capacity is bolstered at the expense of INDOPACOM sea‑denial and strategic deterrence. That forces primes and their subcontractors into a production re‑prioritization cycle that favors tactical velocity (overtime, overtime premium suppliers, expedited logistics) over balanced platform sustainment, raising per‑unit manufacturing costs and lengthening non‑expedited lead times for other programs.

For Lockheed and its supply chain, this is a multi‑quarter to multi‑year revenue/timing arbitrage: accelerated production and service/maintenance demand will lift top‑line visibility, but margin profile will be volatile as the company pays for capacity expansion and supply‑chain CapEx. The political and budgetary backdrop is a key amplifier — an emergency supplemental or sustained conflict drives upside to booked OEM orders and aftermarket services, while rapid de‑escalation quickly crystallizes inventory risk and forces cancellations or slower conversion of that booked demand.

Market impacts are second‑order and asymmetric: smaller propulsion, seeker and avionics suppliers will see outsized margin variability and cash‑flow strain if primes push for faster deliveries, creating acquisition targets or bankruptcy risk over 12–36 months. For investors, the risk window is near term (days–weeks) around operational/casualty headlines and congressional funding votes, and medium term (6–24 months) around production‑capacity ramp outcomes; a reversal would come from either a credible diplomatic pause or a rapid domestic production scale‑up funded and executed without cost overruns.

Key Decisions for Investors

• Initiate a tactical overweight in LMT via a 9–18 month LEAP call position (buy-dated calls or a call spread to control premium). Rationale: benefits from higher OEM production and persistent MRO/service flows. Position size: 2–4% of equity portfolio; stop: pare if headline de‑escalation occurs and the Pentagon signals a cancelation or down‑order within 30 days. Risk/Reward: asymmetric — limited premium risk vs multi‑quarter revenue/margin re‑rating on supplemental funding.
• Pair trade to express relative conviction: long LMT / short RTX (moderate size). Rationale: Lockheed captures more of the long‑range strike and weapons production aftermarket; RTX has broader industrial exposure and potential saturation in cruise missile upgrades. Time horizon: 6–12 months. Risk control: keep gross exposure balanced and tighten if Congressional supplemental is delayed beyond 90 days.
• Event‑driven hedge: buy protection (puts) on broad defense suppliers or use an inverse small position in a defense ETF (e.g., XAR/ITA short) sized at 0.5–1% of portfolio ahead of the congressional supplemental vote. Rationale: headlines, high‑casualty events, or negative funding outcomes can cause quick re‑pricing in the sector over days. Exit: unwind after funding vote outcome or 30 days post‑resolution.
• Watchlist and catalysts: monitor (a) Pentagon procurement notices for expedited production awards (2–12 weeks), (b) emergency supplemental vote timing (30–90 days), and (c) supplier margin guidance from tier‑1 subcontractors in quarterly reports. Use these triggers to scale positions; if material procurement awards are issued without commensurate funding, reduce exposure due to funded execution risk.